Qing is a seasoned venture investor based in Silicon Valley and an industry thought leader at the intersection of AI, life sciences, and healthcare. Her investment focus spans drug development, precision medicine, and synthetic biology, where she supports innovations that bridge cutting-edge science with real-world impact.

Qing serves on the boards of both public and private companies and has held CXO roles as a venture builder, building technologies from patent to market. She is also the founder of DaVinci Café, a community of deep tech founders, scholars, and industry leaders advancing cross-disciplinary innovation.

Before her venture career, Qing practiced as a physician at Singapore General Hospital and conducted research at the Broad Institute of MIT and Harvard. She holds a B.S. and M.D. from Tsinghua University and an MBA from Columbia Business School.